Abstract:
A computer-implemented process for controlling a vehicle interior includes detecting a previously defined situation that relates to an undesirable environmental condition of the vehicle interior, and assessing both a risk level and an urgency level, based on a vehicle sensor input and vehicle historical records. The process also includes generating a vehicle command based upon the detected previously defined situation, the assessed risk level, and assessed urgency level, and executing the generated vehicle command to control at least one of an engine, a window, and a heating, ventilation and air conditioning (HVAC) unit to modify an environmental condition of the vehicle interior. The process also comprises performing in a cyclically recurring manner, until the detected previously defined situation is resolved, re-assessing the risk level, the urgency level, or both, re-generating a vehicle command, and executing the re-generated vehicle command.
Abstract:
A method for node communication for use in a rack system is provided. The method includes providing a detecting unit for connecting to the nodes via a circuit switching device; predefining a linked list in which a limit of times for the detecting unit to communicate with each of the nodes is set; sequentially selecting one node of the nodes so that the detecting unit is connected to the one node via the circuit switching device; adding an assigned communication parameter between the detecting unit and the one node selected to the linked list, wherein a number of times of communication corresponding to the assigned communication parameter is not greater than the limit of times; and performing communication between the detecting unit and the one node selected in accordance with the assigned communication parameter in the linked list.
Abstract:
A method for controlling a rack system including a plurality of detachable chassis, where at lease one node is disposed in the chassis and a rack management controller (RMC) is disposed in the rack system. First, at least one detecting unit connected to the RMC and the node of the chassis in the rack system is provided. Next, a status message of the chassis is detected for determining whether the status of the chassis is changed. When the status is changed, the detecting unit determines whether the node corresponding to the chassis exists in the rack system. When the node exists, the detecting unit acquires a message of a field replaceable unit (FRU) of the node. Thereafter, the detecting unit transmits the message of the FRU to the RMC. Then, the RMC determines a type of the node according to the message of the FRU.
Abstract:
The present invention relates to a novel crystalline form of a Compound 3,4′,5-trihydroxy-stilbene-3-β-D-glucoside (polydatin) and a method of preparation and use thereof, and to a pharmaceutical composition containing crystalline form I of 3,4′,5-trihydroxy-stilbene-3-β-D-glucoside. Crystalline form I of 3,4′,5-trihydroxy-stilbene-3-β-D-glucoside of the present invention has a stable crystalline morphology, a definite melting point and a good chemical stability. Such a novel form of 3,4′,5-trihydroxy-stilbene-3-β-D-glucoside possesses the properties required for the preparation of solid formulations and is easily tabletable and readily formable when formulated, which allows for substantial decrease in raw materials costs, more facile operations in production and easier control over quality in industrial drug production, and moreover, better convenience in storage.
Abstract:
Disclosed is a depolymerized glycosaminoglycan from Thelenota ananas (dTHG), weight average molecular weight of which is about 8000˜20000 Da, and monosaccharide components of which are acetylgalactosamine (GalNAc), glucuronic acid (GlcUA), fucose (Fuc) or their sulfates (expressed as —OSO3−), in which molar ratio of GalNAc:GlcUA:Fuc:—OSO3− is about 1:(1±0.3):(1±0.3):(3.5±0.5). Said dTHG is a potent endogenous inhibitor of factor X, which has good anticoagulant and antithrombotic activity, and can be used for the prevention and/or treatment of thrombotic diseases. Also provided is a method for preparing said dTHG, which comprises steps of 1) extracting and obtaining fucosylated glycosaminoglycan (THG) from the body wall of Thelenota ananas; 2) depolymerizing THG to obtain dTHG by method of peroxide depolymerization or method of peroxide depolymerization catalyzed by catalyst of the fourth period transition metal ions; 3) removing impurities with lower and/or higher molecular weight in dTHG.
Abstract:
Chemically-defined, non-polymeric valency platform molecules and conjugates comprising chemically-defined valency platform molecules and biological or chemical molecules including polynucleotide duplexes of at least 20 base pairs that have significant binding activity for human lupus anti-dsDNA autoantibodies.
Abstract:
Chemically-defined, non-polymeric valency platform molecules and conjugates comprising chemically-defined valency platform molecules and biological or chemical molecules including polynucleotide duplexes of at least 20 base pairs that have significant binding activity for human lupus anti-dsDNA autoantibodies.
Abstract:
Chemically-defined, non-polymeric valency platform molecules and conjugates comprising chemically-defined valency platform molecules and biological or chemical molecules including polynucleotide duplexes of at least 20 base pairs that have significant binding activity for human lupus anti-dsDNA autoantibodies.